ES2105193T3 - Compuestos triciclicos que contienen heteroatomos. - Google Patents
Compuestos triciclicos que contienen heteroatomos.Info
- Publication number
- ES2105193T3 ES2105193T3 ES93810325T ES93810325T ES2105193T3 ES 2105193 T3 ES2105193 T3 ES 2105193T3 ES 93810325 T ES93810325 T ES 93810325T ES 93810325 T ES93810325 T ES 93810325T ES 2105193 T3 ES2105193 T3 ES 2105193T3
- Authority
- ES
- Spain
- Prior art keywords
- heteroatomes
- compounds
- compounds containing
- tricyclic compounds
- antiproliferative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE LAS FORMULAS I, II Y III EN LAS QUE LOS SUSTITUYENTES TIENEN SIGNIFICADOS DIVERSOS. LOS COMPUESTOS PUEDEN PREPARARSE MEDIANTE DIFERENTES METODOS, POR EJEMPLO ACILACION, REDUCCION, ALQUILACION, ETC. LOS COMPUESTOS ESTAN INDICADOS PARA SU USO COMO COMPUESTOS FARMACEUTICOS, EN PARTICULAR COMO AGENTES INMUNOSUPRESORES, ANTIPROLIFERATIVOS Y ANTIINFLAMATORIOS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929209815A GB9209815D0 (en) | 1992-05-07 | 1992-05-07 | Organic compounds,processes for their production and their use |
| GB939304927A GB9304927D0 (en) | 1993-03-10 | 1993-03-10 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2105193T3 true ES2105193T3 (es) | 1997-10-16 |
Family
ID=26300836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93810325T Expired - Lifetime ES2105193T3 (es) | 1992-05-07 | 1993-05-04 | Compuestos triciclicos que contienen heteroatomos. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5514685A (es) |
| EP (1) | EP0569337B1 (es) |
| JP (1) | JP2788392B2 (es) |
| KR (1) | KR100292311B1 (es) |
| CN (1) | CN1037773C (es) |
| AT (1) | ATE155787T1 (es) |
| AU (1) | AU668152B2 (es) |
| CA (1) | CA2095659C (es) |
| CY (1) | CY2126B1 (es) |
| CZ (1) | CZ291773B6 (es) |
| DE (1) | DE69312386T2 (es) |
| DK (1) | DK0569337T3 (es) |
| ES (1) | ES2105193T3 (es) |
| FI (2) | FI982476A0 (es) |
| GR (1) | GR3024754T3 (es) |
| HU (2) | HUT66531A (es) |
| IL (1) | IL105607A (es) |
| MY (1) | MY109602A (es) |
| NO (1) | NO305865B1 (es) |
| NZ (1) | NZ247553A (es) |
| PH (1) | PH30456A (es) |
| RU (1) | RU2126009C1 (es) |
| SG (1) | SG47011A1 (es) |
| SK (1) | SK282061B6 (es) |
| TW (1) | TW330936B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY110603A (en) * | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
| DK0786986T3 (da) | 1994-10-26 | 2002-04-29 | Novartis Ag | Anvendelse af en umættet fedtalkohol |
| GB9421613D0 (en) * | 1994-10-26 | 1994-12-14 | Sandoz Ltd | Organic compounds |
| MY129435A (en) | 1994-10-26 | 2007-04-30 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
| AU749623B2 (en) | 1998-03-26 | 2002-06-27 | Astellas Pharma Inc. | Sustained release preparations |
| TR200003108T2 (tr) * | 1998-04-27 | 2001-02-21 | Fujisawa Pharmaceutical Co., Ltd. | İlaç kompozisyonları |
| GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| US7063857B1 (en) | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
| GB0008785D0 (en) | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds |
| RU2206298C2 (ru) * | 2000-09-22 | 2003-06-20 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Способ лечения глаукомы |
| CN101897662B (zh) | 2002-07-23 | 2013-05-22 | 诺瓦提斯公司 | 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物 |
| KR100469917B1 (ko) * | 2002-09-09 | 2005-02-02 | (주)조은식품 | 구수한 호박씨가 첨가된 호박엿 및 그 제조방법 |
| KR100745493B1 (ko) * | 2005-12-16 | 2007-08-03 | 주식회사농심 | 조직감이 향상된 사출 스낵 및 그 제조 방법 |
| WO2011121105A1 (en) * | 2010-04-02 | 2011-10-06 | Tibotec Pharmaceuticals | Macrocyclic integrase inhibitors |
| US10143682B2 (en) | 2014-10-28 | 2018-12-04 | Koushi Yamaguchi | Medicine for improving state of pregnancy, and use thereof |
| AU2019318035A1 (en) | 2018-08-10 | 2021-03-04 | Koushi Yamaguchi | Therapeutic agent for humoral immunity-related diseases in materno-fetal relationship |
| CN113226331A (zh) | 2018-12-18 | 2021-08-06 | 山口晃史 | 用于改善不孕不育症或妊娠状态的药物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3842069A (en) * | 1973-06-21 | 1974-10-15 | Abbott Lab | 4"-deoxy-4"-oxoerythromycin b derivatives |
| US4952605A (en) * | 1983-08-03 | 1990-08-28 | The Regents Of The University Of California | Manoalide analogs |
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| US5254562A (en) * | 1984-12-03 | 1993-10-19 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| EP0364031B1 (en) * | 1988-10-12 | 1992-12-23 | Merck & Co. Inc. | Hydroxide mediated fk-506 rearrangement process |
| CA1316916C (en) * | 1988-10-12 | 1993-04-27 | David Askin | Hydroxide mediated fk-506 rearrangement product |
| JPH07108101B2 (ja) * | 1989-02-28 | 1995-11-15 | オ−クマ株式会社 | リニアアクチュエータ駆動制御装置 |
| WO1990015805A1 (en) * | 1989-06-14 | 1990-12-27 | Sandoz Ltd | Heteroatoms-containing tricyclic compounds |
| EP0413532A3 (en) * | 1989-08-18 | 1991-05-15 | Fisons Plc | Macrocyclic compounds |
| IE904050A1 (en) * | 1989-11-13 | 1991-05-22 | Merck & Co Inc | Aminomacrolides and derivatives having immunosuppressive¹activity |
| US5260301A (en) * | 1990-03-01 | 1993-11-09 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical solution containing FK-506 |
| GB2246350A (en) * | 1990-07-23 | 1992-01-29 | Fujisawa Pharmaceutical Co | Tricyclo compounds |
| US5384316A (en) * | 1990-08-18 | 1995-01-24 | Fisons Plc | 4,16-diazatetracyclo[23.3.1.1.Hu 14,17=b . 0 Hu 4,9 triaconta-16,19-diene-2,3,10-trione derivatives |
| EP0480623A1 (en) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | New halomacrolides and derivatives having immunosuppressive activity |
| WO1992013862A1 (en) * | 1991-02-05 | 1992-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Lactone compounds |
| JP3644957B2 (ja) * | 1991-09-05 | 2005-05-11 | アボット・ラボラトリーズ | 大環式イムノモジュレーター |
-
1993
- 1993-04-22 HU HU9301190A patent/HUT66531A/hu unknown
- 1993-05-04 AT AT93810325T patent/ATE155787T1/de not_active IP Right Cessation
- 1993-05-04 DK DK93810325.6T patent/DK0569337T3/da active
- 1993-05-04 EP EP93810325A patent/EP0569337B1/en not_active Expired - Lifetime
- 1993-05-04 SG SG1996001883A patent/SG47011A1/en unknown
- 1993-05-04 ES ES93810325T patent/ES2105193T3/es not_active Expired - Lifetime
- 1993-05-04 DE DE69312386T patent/DE69312386T2/de not_active Expired - Lifetime
- 1993-05-05 IL IL105607A patent/IL105607A/en not_active IP Right Cessation
- 1993-05-05 PH PH46144A patent/PH30456A/en unknown
- 1993-05-05 MY MYPI93000847A patent/MY109602A/en unknown
- 1993-05-05 NO NO931627A patent/NO305865B1/no not_active IP Right Cessation
- 1993-05-05 SK SK435-93A patent/SK282061B6/sk not_active IP Right Cessation
- 1993-05-05 FI FI982476A patent/FI982476A0/fi unknown
- 1993-05-05 FI FI932035A patent/FI102612B/fi not_active IP Right Cessation
- 1993-05-05 CZ CZ1993829A patent/CZ291773B6/cs not_active IP Right Cessation
- 1993-05-05 NZ NZ247553A patent/NZ247553A/en not_active IP Right Cessation
- 1993-05-06 JP JP5105392A patent/JP2788392B2/ja not_active Expired - Fee Related
- 1993-05-06 CN CN93106551A patent/CN1037773C/zh not_active Expired - Fee Related
- 1993-05-06 KR KR1019930007766A patent/KR100292311B1/ko not_active Expired - Fee Related
- 1993-05-06 AU AU38393/93A patent/AU668152B2/en not_active Ceased
- 1993-05-06 RU RU93005029A patent/RU2126009C1/ru not_active IP Right Cessation
- 1993-05-06 CA CA002095659A patent/CA2095659C/en not_active Expired - Fee Related
- 1993-05-08 TW TW082103599A patent/TW330936B/zh not_active IP Right Cessation
-
1995
- 1995-05-15 US US08/441,492 patent/US5514685A/en not_active Expired - Lifetime
- 1995-06-19 HU HU95P/P00246P patent/HU211135A9/hu unknown
-
1997
- 1997-09-17 GR GR970402399T patent/GR3024754T3/el unknown
-
1999
- 1999-02-03 CY CY9900004A patent/CY2126B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9301129A (es) | Nuevas ciclosporinas y composiciones farmaceuticas que las contienen. | |
| ES2191320T3 (es) | Derivados de piperazina y su uso como agentes anti-inflamatorios. | |
| MX9300498A (es) | Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2124793T3 (es) | Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores. | |
| ES2122043T3 (es) | Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas. | |
| MX9306986A (es) | Composiciones farmaceuticas a base de taxoides. | |
| ES2062239T3 (es) | Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos. | |
| ES2123682T3 (es) | Derivados de 2-ciano-1,3-diona y su empleo como herbicidas. | |
| MX9304581A (es) | Desoxitaxoles y composiciones farmaceuticas que los contienen | |
| MX9308012A (es) | Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen. | |
| AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
| MX9207494A (es) | 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
| FI933424A7 (fi) | Peptidyyli-4-amino-2,2-difluori-3-okso-1,6-heksaanidinihappojohdannaiset tulehdusta vastustavina aineina | |
| AR021596A1 (es) | Compuestos que inhiben la procolageno c-proteinasa. | |
| AR241082A1 (es) | Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol". | |
| ES2160602T3 (es) | Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria. | |
| ES2187738T3 (es) | Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen. | |
| ES2170759T3 (es) | Derivados de galantamina, un procedimiento para su preparacion y su uso como medicamentos. | |
| ECSP941120A (es) | Derivados de 1,5 benzodiazepina | |
| MX9303123A (es) | Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen. | |
| NO931627L (no) | Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika | |
| MX9308006A (es) | Derivados de 4-benzoilisoxazol, procedimiento para su preparcion y composicion herbicida que los comprende. | |
| MX9401080A (es) | Compuestos heteroaromaticos. | |
| MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
| ES2159054T3 (es) | Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 569337 Country of ref document: ES |